Themis Medicare Limited

Themis Medicare Limited (historically known as Themis Chemicals / Themis Pharmaceuticals) is a prominent, research-based Indian multinational pharmaceutical company. Founded in 1952, the company is widely recognized for pioneering the indigenization of critical Active Pharmaceutical Ingredients (APIs) and developing specialized New Drug Delivery Systems (NDDS). Headquartered in Mumbai, Maharashtra, the company is publicly traded on both the National Stock Exchange (NSE: THEMISMED) and the Bombay Stock Exchange (BSE).